Psychosocial Oncology and Clinical Practice Research Group, Leeds Institute of Molecular Medicine, University of Leeds, Beckett Street, Leeds, West Yorkshire, UK.
Psychooncology. 2011 Jan;20(1):36-43. doi: 10.1002/pon.1705.
To develop subscales for clinical use of the Social Difficulties Inventory (SDI) with score interpretation guidance for use in routine oncology practice.
Patient-reported outcome measures are used increasingly in cancer care but successful implementation is dependent on a combination of sound psychometrics, guidance on clinical meaning and good clinical judgement. The SDI, a 21-item instrument (SDI-21) developed for use in cancer care, demonstrated good psychometric properties. Rasch analysis of the SDI resulted in a 16-item interval scale of Social Distress (SD-16), which allowed for establishment of some clinical utility guidance but further work was required to optimise meaningful interpretation in clinical practice.
Data were pooled from three studies investigating psychometrics and clinical utility of the SDI-21.
Common factor analysis was undertaken on SD-16 items. Subscales were derived from the resulting factors and calculated by summing the scores of associated items. Subscale reliability was evaluated using Cronbach's α.
There were 652 participants. A three-factor model explaining 53.3% of the variance was extracted forming the basis of the subscales: Everyday living, Money matters and Self and others. Subscale reliability was good. In a clinical setting, a 2-point change in subscale score could be interpreted as a clinically meaningful difference.
The development of three subscales and clinically significant difference scores for the SD-16, combined with the previously developed cut-off points, improves the clinical utility of the SDI-21 when assessing social issues in oncology care.
开发社会困难量表(SDI)的子量表,为常规肿瘤学实践提供评分解释指导。
患者报告的结果测量指标在癌症护理中越来越多地使用,但成功实施取决于良好的心理测量学、对临床意义的指导和良好的临床判断的结合。SDI 是一种为癌症护理开发的 21 项工具(SDI-21),具有良好的心理测量学特性。SDI 的 Rasch 分析产生了一个 16 项社会困扰(SD-16)的区间量表,这为建立一些临床实用指南提供了依据,但需要进一步工作来优化在临床实践中的有意义解释。
数据来自三项研究,研究了 SDI-21 的心理测量学和临床实用性。
对 SD-16 项目进行了共同因素分析。从所得因子中衍生出子量表,并通过将相关项目的得分相加来计算。子量表的可靠性采用 Cronbach's α 进行评估。
共有 652 名参与者。提取出一个解释方差 53.3%的三因素模型,形成子量表的基础:日常生活、金钱问题和自我与他人。子量表的可靠性良好。在临床环境中,子量表得分的 2 分变化可被解释为具有临床意义的差异。
SD-16 的三个子量表和具有临床意义的差异评分的开发,以及之前开发的临界点,提高了 SDI-21 在评估肿瘤学护理中的社会问题时的临床实用性。